MedX Health Corp (MDX):企業の財務・戦略的SWOT分析

◆英語タイトル:MedX Health Corp (MDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14465
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and dental laser console system. It develops SIAscope, a handheld scanner designed for dermatologists, general practitioners and skin specialists. MedX’s molemate is a software image management system that displays dermatoscopic view, hemoglobin view, melanin view, dermal melanin view and collagen view. The company offers SIMSYS-molemate skin imaging system, a non-invasive skin screening procedure for moles and lesions. It serves practitioners in clinics, academic facilities, hospitals long-term care facilities, athletes and sports teams. MedX is headquartered in Mississauga, Ontario, Canada.

MedX Health Corp Key Recent Developments

Mar 04,2019: MedX Health announces private label distributor agreement for selected therapeutic laser products with Richmar in US
Mar 04,2019: MedX Health Corp. Announces Private Label Distributor Agreement for Selected Therapeutic Laser …
Dec 27,2018: MedX Health announces that Dr. Bruno Battistini, an accomplished canadian-based health care researcher has joined its medical advisory board
Nov 27,2018: MedX Signs MOU to Launch DermSecure in the Netherlands
Sep 24,2018: MedX Health announces board and executive changes

This comprehensive SWOT profile of MedX Health Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of MedX Health Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

MedX Health Corp – Key Information
MedX Health Corp – Overview
MedX Health Corp – Key Employees
MedX Health Corp – Key Employee Biographies
MedX Health Corp – Key Operational Heads
MedX Health Corp – Major Products and Services
MedX Health Corp – History
MedX Health Corp – Company Statement
MedX Health Corp – Locations And Subsidiaries
MedX Health Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

MedX Health Corp – Business Description
MedX Health Corp – Corporate Strategy
MedX Health Corp – SWOT Analysis
SWOT Analysis – Overview
MedX Health Corp – Strengths
MedX Health Corp – Weaknesses
MedX Health Corp – Opportunities
MedX Health Corp – Threats
MedX Health Corp – Key Competitors

Section 3 – Company Financial Performance Charts

MedX Health Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

MedX Health Corp, Key Information
MedX Health Corp, Key Ratios
MedX Health Corp, Share Data
MedX Health Corp, Major Products and Services
MedX Health Corp, History
MedX Health Corp, Key Employees
MedX Health Corp, Key Employee Biographies
MedX Health Corp, Key Operational Heads
MedX Health Corp, Other Locations
MedX Health Corp, Subsidiaries
MedX Health Corp, Key Manufacturing facilities
MedX Health Corp, Key Competitors
MedX Health Corp, SWOT Analysis
MedX Health Corp, Ratios based on current share price
MedX Health Corp, Annual Ratios
MedX Health Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

MedX Health Corp, Performance Chart
MedX Health Corp, Ratio Charts

★海外企業調査レポート[MedX Health Corp (MDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報
    Summary Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondar …
  • Abbott Vascular Inc:医療機器:M&Aディール及び事業提携情報
    Summary Abbott Vascular Inc (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Laboratories, is a medical device company that develops manufactures and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. It …
  • Steris Corp:医療機器:M&Aディール及び事業提携情報
    Summary Steris Corp (Steris), formerly Innovative Medical Technologies, a subsidiary of Steris Plc, is a medical device company which offers infection prevention and other procedural products and services. The company offers surgical equipment and image management devices, sterile processing equipme …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …
  • NovoCure Ltd (NVCR):製薬・医療:M&Aディール及び事業提携情報
    Summary NovoCure Ltd (NovoCure) is an drug company that offers development and commercialization of novel therapies for tumor treating fields. The company’s pipeline products find application in cancer indications such as malignant melanoma, hepatocellular carcinoma, ovarian cancer, breast cancer an …
  • Kangwon Land Inc.:企業の戦略・SWOT・財務分析
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Genesis Energy, L.P.:企業の戦略・SWOT・財務分析
    Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Tesla Energy Operations Inc:企業の戦略的SWOT分析
    Tesla Energy Operations Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Forum Energy Technologies, Inc.:戦略・SWOT・企業財務分析
    Forum Energy Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forum Energy Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • DBV Technologies SA (DBV):企業の財務・戦略的SWOT分析
    Summary DBV Technologies SA (DBV) is a biopharmaceutical company that develops products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare markets. Its viaskin technology platform …
  • Balfour Beatty plc:企業の戦略・SWOT・財務情報
    Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report Summary Balfour Beatty plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Enel SpA (ENEL)-エネルギー分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Inivata Ltd:企業の製品パイプライン分析
    Summary Inivata Ltd (Inivata) is a cancer genomics company that harnesses liquid biopsy platform to enhance personalized healthcare in oncology. The company’s product portfolio includes InVisionFirst – Lung, which offers advanced sequencing technology to detect copy number variants, single nucleotid …
  • Spanish National Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary Spanish National Cancer Research Center (CNIO) is a medical research center that offers cancer research programs. The center is an integral cancer research institute which integrates basic and translational cancer research. It conducts various scientific programs which include molecular onco …
  • Isramco Inc (ISRL):企業の財務・戦略的SWOT分析
    Summary Isramco Inc (Isramco), a subsidiary of Israel Oil Company Ltd, is an oil and gas company that offers exploration, production and development of oil and natural gas properties. The company acquires, explores, develops and produces oil and natural gas resources. It offers services such as work …
  • Universal Electronics Inc (UEIC):企業の財務・戦略的SWOT分析
    Summary Universal Electronics Inc (Universal Electronics) is a technology company that offers control and sensor technology solutions. The company offers a range of pre-programmed and universal remote control products, audio-video accessories, intelligent wireless security and automation components, …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • AVX Corporation (AVX):企業の財務・戦略的SWOT分析
    AVX Corporation (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • IGas Energy PLC (IGAS):企業の財務・戦略的SWOT分析
    IGas Energy PLC (IGAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Ajinomoto Co Inc (2802):企業の財務・戦略的SWOT分析
    Ajinomoto Co Inc (2802) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆